Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ASCO 2023 - Breast Cancer
AMCP Nexus 2022
ASCO 2022 - Wrap Up
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Laura Morgan
Authored Articles
ASCO Names the 14 Oncology Practices Participating in the 2016 Quality Training Program, Highlighting Significant Improvements in Care Delivery
Laura Morgan
Oncology Practice
October 2016, Vol 7, No 9
Read Article
New Anticancer Drugs Increase Costs but Prolong Life
Laura Morgan
Value in Oncology
October 2016, Vol 7, No 9
Read Article
NCI’s Acting Director: Data-Sharing, Immunotherapy, and the Cancer Moonshot Initiative
Laura Morgan
Cancer Moonshot
September 2016, Vol 7, No 8
Read Article
Defitelio (Defibrotide Sodium): First Drug Approved for Patients with Hepatic Veno-Occlusive Disease
Laura Morgan
Drug Updates
July 2016, Vol 7, No 6
Read Article
Osimertinib Effective for First-Line Treatment of EGFR Mutation–Positive NSCLC
Laura Morgan
Lung Cancer
,
Solid Tumors
June 2016, Vol 7, No 5
Read Article
American Cancer Society Updates Breast Cancer Screening Guidelines for Women at Average Risk
Laura Morgan
Breast Cancer
,
Solid Tumors
December 2015, Vol 6, No 11
Read Article
Patients with Cancer Eager to Discuss Costs of Care with Their Oncologists
Laura Morgan
Economics & Value
,
Economics of Cancer Care
September 2015, Vol 6, No 8
Read Article
Medical and Psychosocial Impact of Oral Therapy on Patients with Metastatic Castration-Resistant Prostate Cancer
Laura Morgan
Prostate Cancer
,
Solid Tumors
September 2015, Vol 6, No 8
Read Article
ASCO Develops New Framework to Evaluate the Value of Cancer Therapies
Laura Morgan
ASCO’s Value Framework
July 2015, Vol 6, No 6
Read Article
Biomarker Testing Trends in Europe Linked to Availability of Specific Targeted Cancer Drugs
Laura Morgan
Personalized Medicine
June 2015, Vol 6, No 5
Read Article
The New PC-SAF Instrument: A Patient-Reported Outcome Tool for Identifying the Symptoms of Pancreatic Cancer
Laura Morgan
Economics & Value
,
Economics of Cancer Care
June 2015, Vol 6, No 5
Read Article
Increasing Use of Value Analysis Committees in US Hospitals: Implications for Healthcare Providers and Manufacturers
Laura Morgan
Economics & Value
,
Economics of Cancer Care
June 2015, Vol 6, No 5
Read Article
Early Initiation of Palliative Care Improves Survival in Patients with Advanced Cancer
Laura Morgan
Palliative Care
,
Personalized Medicine
June 2015, Vol 6, No 5
Read Article
Health Plan Cost-Savings with Netupitant/Palonosetron for the Prevention of CINV
Laura Morgan
Economics & Value
,
Economics of Cancer Care
May 2015, Vol 6, No 4
Read Article
Real-World Treatment Patterns of Axitinib for Advanced Renal-Cell Carcinoma
Laura Morgan
Economics & Value
,
Economics of Cancer Care
May 2015, Vol 6, No 4
Read Article
Substantial Costs Associated with Systemic Therapy After Ipilimumab in Patients with Advanced Melanoma
Laura Morgan
Economics & Value
,
Economics of Cancer Care
May 2015, Vol 6, No 4
Read Article
Medicare’s Sustainable Growth Rate Repeal Met with Relief
Laura Morgan
Economics & Value
,
Economics of Cancer Care
May 2015, Vol 6, No 4
Read Article
Comparing the Safety and Efficacy of Stereotactic Radiotherapy versus Surgery in Lung Cancer
Laura Morgan
Lung Cancer
,
Solid Tumors
October 2014, Vol 5 , No 8
Read Article
IOM’s Call to Action on End-of-Life Care in the United States
Laura Morgan
End-of-Life Care
,
Policies & Guidelines
October 2014, Vol 5 , No 8
Read Article
Oncologists Show Low Genomic Confidence about the Use of Genetic Testing
Laura Morgan
Personalized Medicine
September 2014, Vol 5, No 7
Read Article
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
2.
AI and ML Decision Support Models
3.
Crystal S. Denlinger, MD, FACP, Named New CEO of NCCN
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ASCO 2023 - Breast Cancer
AMCP Nexus 2022
ASCO 2022 - Wrap Up
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Subscribe Today!
To sign up for our newsletter or print publications, please enter your contact information below.
I'd like to receive:
VBCC
Print Edition
VBCC
Weekly e‑Newsletter
-- Please Select --
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, the Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, the former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
I have reviewed and consent to the terms of
VBCC
's
Privacy Policy
, and
VBCC
has my permission to retain my information in its database, and to forward pertinent communications to me.
START YOUR SUBSCRIPTION